Drugs / ZS802
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05523128 | Sep 2022 → Oct 2025 | hemophilia A | Institute of Hematology & Blood Diseases Hospital, China | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZS802 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05523128 ↗ |
| Modality | Gene therapy (AAV / viral vector) | “adeno-associated viral (AAV) vector” NCT05523128 ↗ |
| Route | Intravenous | “single IV infusion of ZS802” NCT05523128 ↗ |